000650 Renhe Pharmacy
- 5.90
- +0.20+3.51%
Renhe Pharmacy News
Renhe Pharmaceutical: Announcement on the Company\'s wholly-owned subsidiary obtaining approval for supplementary drug applications
Renhe Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Renhe Pharmaceutical: 2024 semi-annual financial report
Renhe Pharmacy: Announcement on the completion of the non-trading transfer of the second phase of the employee shareholding plan by the company.
Renhe Pharmacy: Announcement of the resolution of the first holder meeting of the second phase employee stock ownership plan of the company.
Renhe Pharmacy: Legal Opinion of Renhe Pharmaceutical's 2023 Annual General Meeting of Shareholders
Renhe Pharmacy: Renhe Pharmaceutical Co., Ltd. Phase II Employee Stock Ownership Plan
Renhe Pharmacy: Announcement of Resolutions of the Company's 2023 Annual General Meeting of Shareholders
Renhe Pharmacy: Summary of Renhe Pharmaceutical Co., Ltd. Phase II Employee Stock Ownership Plan (Draft) (Revised Draft)
Renhe Pharmacy: Renhe Pharmaceutical Co., Ltd. Phase II Employee Stock Ownership Plan (Draft) (Revised Draft)
Renhe Pharmacy: Prompt Announcement on Convening the 2023 Annual General Meeting of Shareholders
Renhe Pharmacy: Instructions of the board of directors on the company's second employee stock ownership plan (draft) (revised draft) in accordance with the relevant provisions of the “Guiding Opinions on Implementing Pilot Employee Stock Ownership Plans for Listed Companies”
Renhe Pharmacy: Instructions of the board of directors that the second phase of the company's employee stock ownership plan (draft) complies with the relevant provisions of the “Guiding Opinions on Implementing Pilot Employee Stock Ownership Plans by Listed Companies”
Renhe Pharmacy: Summary of Renhe Pharmaceutical Co., Ltd. Phase II Employee Stock Ownership Plan (Draft)
Renhe Pharmacy: Renhe Pharmaceutical Co., Ltd. Phase II Employee Stock Ownership Plan (Draft)
Renhe Pharmaceutical: Report on the performance of supervisory duties by the Company Audit Committee on accounting firms
Renhe Pharmaceutical: Internal Control Self-Evaluation Report
Renhe Pharmaceutical: Notice of Annual General Meeting of Shareholders
Renhe Pharmaceutical: Announcement on preparation for impairment of assets accrued in 2023
Renhe Pharmaceutical: Announcement on the use of own funds for investment and financial management
Analysis
Price Target
No Data
No Data